COMMUNIQUÉS West-GlobeNewswire

-
GW Pharmaceuticals plc Announces the Sale of Priority Review Voucher for $105M
18/03/2019 -
Kiniksa Presents Rilonacept Interim Phase 2 Clinical Data Poster at the American College of Cardiology’s 68th Annual Scientific Session
18/03/2019 -
Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Morgan from the Board
18/03/2019 -
CMR Surgical strengthens Board of Directors
18/03/2019 -
Nicox présente des données non cliniques sur le NCX 4251, une nouvelle thérapie pour la blépharite, dans un poster à l'AGS 2019 Annual Meeting
18/03/2019 -
Nicox Poster Presentation at AGS 2019 Annual Meeting Discloses Preclinical Data for NCX 4251, a Novel Blepharitis Therapy
18/03/2019 -
Alcon Announces Acquisition of PowerVision, Inc.
18/03/2019 -
MDxHealth (R): MDxHealth Announces Positive Data from Pan-European Clinical Validation Study of SelectMDx
18/03/2019 -
MDxHealth (R) : MDxHealth annonce des données positives provenant d'une étude paneuropéenne Étude de validation clinique de SelectMDx
18/03/2019 -
Bone Therapeutics to present data at Herbert Fleisch / IFMRS Workshop
18/03/2019 -
DEFINE PCI study finds treatable cause for significant rates of residual ischemia in coronary stent patients
17/03/2019 -
Full Results from PhaseBio Phase 1 Clinical Trial of PB2452 Published in the New England Journal of Medicine and Presented at the American College of Cardiology’s 68th Annual Scientific Session
17/03/2019 -
New Clinical Trial Shows Medtronic TYRX(TM) Envelope Signficantly Reduces Major Infections in Cardiac Implantable Device Patients
17/03/2019 -
High Risk of Atherosclerotic Cardiovascular Events Projected in People with Elevated Triglycerides Without Established Atherosclerotic Cardiovascular Disease
16/03/2019 -
Medtronic Evolut Low Risk Trial Meets Primary Endpont
16/03/2019 -
The Woman’s Hospital of Texas Welcomes Sextuplets!!
16/03/2019 -
Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease
16/03/2019 -
Allergy Standards Ltd deepens footprint in the ‘Bay Area’ as Irish Minister for Health visits
15/03/2019 -
Helix BioPharma Corp. Closes Private Placement, Extends Period to Exercise Warrants and Provides Corporate Update
15/03/2019
Pages